A Multicenter, Retrospective, Observational Study to Evaluate the Efficacy and Tolerability of Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer who Progress after Docetaxel and Abiraterone Treatment.
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Dec 2015 New trial record